Tag: Psoriasis
FDA Approves Siliq for Plaque Psoriasis
Injected medication approved for use by patients who've failed other treatments
Fatigue Occurs in ~50 Percent With Chronic Plaque Psoriasis
Objective measures of psoriasis disease activity are not associated with fatigue severity
Psoriasis Impacts QoL for Parents of Affected Children
Negative impact on quality of life in multiple domains, especially emotional well-being
Consultations Rarely Address Psoriasis Patients’ Concerns
Patients report wanting to be met as individuals, prefer individualized health education
Reduction in Psoriasis Symptoms With Long-Term Weight Loss
Quality-of-life boost seen in obese patients who lost significant amounts of weight
Fatigue Levels Vary for Patients With Psoriatic Disease
Higher levels of fatigue in psoriatic arthritis versus psoriasis; fatigue scores linked to depression
Gastric Bypass Associated With Reduced Risk of Psoriasis
Reduced risks of psoriasis, severe psoriasis, psoriatic arthritis with bypass, but not banding
Prenatal Exposure to Maternal Stress May Raise Psoriasis Risk
But link to psoriasis seen only for children born to mothers who lost a partner/spouse or an older child
Rapid, Clinically Meaningful Psoriasis Relief With Ixekizumab
Three clinical trials show significant improvements for ixekizumab versus etanercept, placebo
Increased Global, Subcutaneous Inflammation in Psoriasis
Increased 18F-fluorodeoxyglucose uptake values indicate arterial and subcutaneous inflammation
